COMMUNIQUÉS West-GlobeNewswire

Molecular Templates to Present at the Cowen and Company 38th Annual Health Care Conference
08/03/2018
AUSTIN, Texas, March 08, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq: MTEM ) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new [...]
HempAmericana to Uplist Shares as Company Seeks to Dominate the $2.1B CBD Oil Market
08/03/2018
NEW YORK, March 08, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- HempAmericana, Inc. (OTC:HMPQ) (“HempAmericana” or the “Company”) is excited to announce that it has begun the process of uplisting the Company’s trading [...]
Interpace Diagnostics Announces Additional Coverage of Thyroid Tests
08/03/2018
PARSIPPANY, N.J., March 08, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG ) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that provides clinically [...]
Aeglea BioTherapeutics Doses First Uveal and Cutaneous Melanoma Patients in Phase 1 Cohort Expansions with Pegzilarginase
08/03/2018
AUSTIN, Texas, March 08, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE ), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with [...]
Selecta Biosciences to Report Fourth Quarter and Year End 2017 Financial Results on Thursday, March 15, 2018
08/03/2018
WATERTOWN, Mass., March 08, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB ), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by avoiding [...]
Progenics Pharmaceuticals Announces Fourth Quarter and Full-Year 2017 Financial Results and Business Update
08/03/2018
Company Preparing for Potential Commercial Launch of AZEDRA® (iobenguane I 131) Ahead of U.S. Food and Drug Administration (FDA) April 30th Action Date Enrollment Complete in Phase 3 Trial for PSMA-Targeted SPECT/CT [...]
Innate Pharma Hosts R&D Day Today in London
08/03/2018
Innate Pharma Hosts R&D Day Today in London Innate Pharma presents a clinical update on its broad and diverse development portfolio of first- or best-in-class antibodies in immuno-oncology Update on the development [...]
Présentation R&D d'Innate Pharma ce jour à Londres
08/03/2018
Présentation R&D d'Innate Pharma ce jour à Londres Innate Pharma présente les avancées cliniques de son portefeuille d'anticorps innovants et diversifié en immuno-oncologie Mise à jour du programme de développement [...]
Marinus Pharmaceuticals to Present at the Barclays Global Healthcare Conference
08/03/2018
RADNOR, Pa., March 08, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS ), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric [...]
Neos Therapeutics to Host Fourth Quarter and Year-End 2017 Financial Results Conference Call on March 15, 2017
08/03/2018
DALLAS and FORT WORTH, Texas, March 08, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ: NEOS ), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR [...]
Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Results
08/03/2018
DUBLIN, Ireland, March 08, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL ), "Avadel" or "the Company," today announced its financial results for the fourth quarter and full year 2017. Highlights [...]
TG Therapeutics, Inc. Announces Fourth Quarter and Year-End 2017 Financial Results and Business Update
08/03/2018
NEW YORK, March 08, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX ) today announced its financial results for the fourth quarter and year ended December 31, 2017 and provided recent company developments [...]
Stemline Therapeutics to Present at Upcoming Investor Conferences
08/03/2018
NEW YORK, March 08, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML ), a clinical-stage biopharmaceutical company developing novel therapeutics for difficult to treat cancers, announced today that [...]
Ossur Hf : New share option program
08/03/2018
Announcement no. 19/2018 Reykjavik, 8 March 2018 New share option program Enclosed information on a new share option program for the CEO and other members of the Executive Management, their direct reports (with [...]
Ossur Hf : Board decisions following the Annual General Meeting
08/03/2018
Announcement no. 18/2018 Reykjavik, 8 March 2018 Board decisions following the Annual General Meeting Enclosed are the Board decisions following the Annual General Meeting of Össur hf. held today, Thursday 8 March 2018 [...]
Aptose To Release Fourth Quarter and Year End December 31, 2017 Financial Results and Hold Conference Call on March 27, 2018
08/03/2018
SAN DIEGO and TORONTO, March 08, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO ) (TSX: APS ), a clinical-stage biotechnology company developing first-in-class agents that target the dysregulated [...]
Melinta Therapeutics Partner, Menarini Group, Submits Marketing Authorization Application for Delafloxacin in Europe
08/03/2018
NEW HAVEN, Conn., March 08, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, today [...]
Onconova Therapeutics, Inc. Reports Business Highlights and Full Year 2017 Financial Results
08/03/2018
NEWTOWN, Pa., March 08, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX ), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat [...]
Ossur Hf : Results of the Annual General Meeting
08/03/2018
Announcement no. 17/2018 Reykjavik, 8 March 2018 Results of the Annual General Meeting Enclosed are the results of the Annual General Meeting of Össur hf. held today, Thursday 8 March 2018. The Icelandic Register of [...]

Pages